menu ☰
menu ˟

Sirion, Acucela sign deal for gene therapy development

12 Jan 2018
Sirion Biotech and Acucela have signed a 2-year development agreement to establish optimized adeno-associated virus vectors for clinical applications in ocular gene therapy, according to a Sirion press release.Through the agreement, which Acucela is ...

Click here to view the full article which appeared in Optometry

IPH Logo